These video-based roundtable discussions highlight key COPD updates provided at a May 2017 meeting on pulmonary disease. Expert faculty reflect on new information on COPD and discuss the impact it has for patients.

 

Conference Coverage

Drs. James F. Donohue and Gary T. Ferguson address the following questions:

  • What are the changes regarding general assessment and management of COPD?
  • Should you ever think of using more than one long-acting bronchodilator as initial therapy (LAMA vs LABA/LAMA)?
  • What are the changes in the new recommendations regarding the use of ICS?

Conference Coverage

Drs. Gary T. Ferguson and James F. Donohue address the following questions:

  • What are new findings related to LAMA/LABA fixed dose combinations?
  • What are the considerations and issues with stepping up to triple therapy?
  • When is it safe and appropriate to step down from triple therapy to a LAMA/LABA fixed dose combination?

Conference Coverage

Drs. Gary T. Ferguson and Nicola A. Hanania address the following questions:

  • How often should the importance of optimizing inhaled delivery devices and patient preference/needs be reviewed?
  • What are the clues that an inhaled delivery system might not be working well for a specific patient?
  • What is known about gaps between patients and pulmonologists with regard to inhaler devices systems?

Access other Therapeutic Areas: